“Together, T3 Labs and Veranex can deliver more integrated, valuable, customized services to the medtech community. We look forward to the impact we can make together.”
DVM, SVP, Preclinical Services – US at Veranex
Expanding Our Preclinical Services and Accessibility in North Amercia
Recently Veranex acquired T3 Labs, a state-of-the-art, highly reputable preclinical laboratory located in Atlanta, Georgia. This acquisition solidifies our commitment to expanding our preclinical footprint in North America, supporting the increasing regulatory demands and enabling more efficient collaboration with clients in their product development.
Deeper Therapeutic Expertise
While our Paris lab is already well-known as a preeminent leader within the cardiovascular space, the addition of our North American facility brings a broader array of cardiovascular and non-cardiovascular expertise into our portfolio of offerings. We’ve expanded our capabilities to encompass 12 total therapeutic areas including orthopedic, GI/urology, and more as well as offering bioskills training. The staff at T3 Labs brings deep preclinical medical device expertise to our existing team, having contributed to more than 60 products being approved by the FDA over the past 10 years.
Preclinical Operating Room
PCS Histopathology image
At the Center of the Lifescience Community
As an anchor in Science Square, a growing life sciences hub in Atlanta, Georgia, T3 Labs shares community relationships with prominent institutions including the Centers for Disease Control and Prevention (CDC), local universities, and others.
The location of our new North American lab also facilitates on-site interactions with North American regulatory bodies. As safety and efficacy data requirements for preclinical studies continue to increase, having a convenient North American location will simplify working with regulatory bodies, supporting cost savings and accelerated development timelines. This acquisition furthers our commitment to our clients as an integrated, end-to-end service provider for medtech innovation from idea conception through regulatory approval.
“The addition of T3 Labs to the Veranex family allows us to further realize our mission of unifying the entire medtech development process, from concept to commercialization. The growth of the preclinical market, increasing regulatory requirements, and the need for efficient collaboration between customers and product development make T3 Labs a strategic fit for Veranex and an incredible asset for our customers.”
CEO of Veranex
Preclinical lab in Paris
Veranex’s Preclinical At-a-Glance
Serving multiple therapeutic areas and technology categories
Thought leadership and technical expertise provided by 20 full-time veterinarians
In-house comprehensive pathology services
Integrated approach for all study needs from design, engineering, development, regulatory and clinical research, and more
Flexible scheduling to meet client needs with over 10 ORs and cath labs in Paris, France and Atlanta, GA (US) including both conventional and hybrid, creating greater capacity and decreasing wait times